OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 97 filers reported holding OLEMA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,835 | +45.0% | 310,500 | +6.0% | 0.01% | +75.0% |
| Q2 2023 | $2,645 | +196.5% | 292,900 | +13.9% | 0.00% | +300.0% |
| Q1 2023 | $892 | +36.8% | 257,200 | -3.4% | 0.00% | 0.0% |
| Q4 2022 | $652 | -99.9% | 266,200 | -30.0% | 0.00% | 0.0% |
| Q3 2022 | $1,050,000 | -9.9% | 380,500 | +33.0% | 0.00% | 0.0% |
| Q2 2022 | $1,165,000 | +10.5% | 286,134 | +15.7% | 0.00% | 0.0% |
| Q1 2022 | $1,054,000 | -60.9% | 247,332 | +152.6% | 0.00% | -66.7% |
| Q3 2021 | $2,698,000 | – | 97,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $15,238,000 | 2.80% |
| Fairmount Funds Management LLC | 2,669,300 | $10,864,000 | 2.49% |
| BVF INC/IL | 7,611,503 | $30,979,000 | 1.50% |
| Vivo Capital, LLC | 1,689,515 | $6,876,000 | 0.69% |
| Cormorant Asset Management, LP | 2,082,000 | $8,474,000 | 0.64% |
| Newtyn Management, LLC | 500,000 | $2,035,000 | 0.39% |
| Kynam Capital Management, LP | 249,229 | $1,014,000 | 0.26% |
| Monaco Asset Management SAM | 130,000 | $529,000 | 0.23% |
| TANG CAPITAL MANAGEMENT LLC | 318,926 | $1,298,000 | 0.20% |
| Artal Group S.A. | 260,500 | $1,060,000 | 0.06% |